Clinical Trials
29 trialsCOCORIVO
Centre Henri Becquerel
FASN
Wake Forest University Health Sciences
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer
Northwestern University
Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
INSPIRE
Radboud University Medical Center
Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer
Weill Medical College of Cornell University
A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
Cancer Research UK
HTL0039732 in Participants With Advanced Solid Tumours
Cancer Research UK
Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer
University of Iowa
LACOG 1818
Latin American Cooperative Oncology Group
PEACE8
UNICANCER
PSMAxCD3
University Hospital Tuebingen
ANZadapt
Leiden University Medical Center
GUIDE
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects
University of California, San Francisco
COMRADE
Sheffield Teaching Hospitals NHS Foundation Trust
68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer
University of Iowa
REDOSE
Radboud University Medical Center
68Ga PSMA in Preprostatectomy Patients
University of Iowa
225AcPSMAI&T
Erasmus Medical Center
Firefly
Tulane University
OLI-CR-P
Technische Universität Dresden
Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)
Universität des Saarlandes
TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer
West China Hospital
PROSTIRNA
Institut Claudius Regaud
AERA
University of Athens
PTtWES
Changhai Hospital
Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer
British Columbia Cancer Agency
Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate Cancer
Samsung Medical Center